DZ3225A1 - METHOD AND COMPOSITIONS FOR THE TREATMENT OF LUNG DISEASES - Google Patents

METHOD AND COMPOSITIONS FOR THE TREATMENT OF LUNG DISEASES

Info

Publication number: DZ3225A1
Authority: DZ; Algeria
Prior art keywords: compositions; treatment; lung diseases; lung; diseases
Prior art date: 1999-11-02

Application number

DZ003225A

Other languages

French (fr)

Inventor

Peter N Goodfellow

Richard Nieman

Theodore J Torphy

Original Assignee

Smithkline Beecham Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-11-02

Filing date

2000-11-01

Publication date

2001-05-10

2000-11-01 Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp

2001-05-10 Application granted granted Critical

2001-05-10 Publication of DZ3225A1 publication Critical patent/DZ3225A1/en

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pulmonology (AREA)
Epidemiology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

DZ003225A 1999-11-02 2000-11-01 METHOD AND COMPOSITIONS FOR THE TREATMENT OF LUNG DISEASES DZ3225A1 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US16315899P	1999-11-02	1999-11-02
PCT/US2000/030113 WO2001032127A2 (en)	1999-11-02	2000-11-01	Method and compositions for treating pulmonary diseases

Publications (1)

Publication Number	Publication Date
DZ3225A1 true DZ3225A1 (en)	2001-05-10

Family

ID=22588737

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DZ003225A DZ3225A1 (en)	1999-11-02	2000-11-01	METHOD AND COMPOSITIONS FOR THE TREATMENT OF LUNG DISEASES

Country Status (29)

Country	Link
EP (1)	EP1225866A4 (en)
JP (1)	JP2003513028A (en)
KR (1)	KR20020057988A (en)
CN (1)	CN1387404A (en)
AP (1)	AP2002002496A0 (en)
AR (1)	AR029189A1 (en)
AU (1)	AU1357501A (en)
BG (1)	BG106748A (en)
BR (1)	BR0015270A (en)
CA (1)	CA2388333A1 (en)
CO (1)	CO5261512A1 (en)
CZ (1)	CZ20021512A3 (en)
DZ (1)	DZ3225A1 (en)
EA (1)	EA200200518A1 (en)
EC (1)	ECSP003747A (en)
HK (1)	HK1049107A1 (en)
HU (1)	HUP0203152A3 (en)
IL (1)	IL149367A0 (en)
MA (1)	MA26841A1 (en)
MX (1)	MXPA02004350A (en)
NO (1)	NO20022057L (en)
OA (1)	OA12076A (en)
PE (1)	PE20011005A1 (en)
PL (1)	PL355261A1 (en)
SK (1)	SK7592002A3 (en)
TR (1)	TR200201211T2 (en)
TW (1)	TWI242431B (en)
WO (1)	WO2001032127A2 (en)
ZA (1)	ZA200203435B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2459757C (en) *	2001-09-19	2011-08-30	Altana Pharma Ag	Combination
MXPA04003668A (en) *	2001-10-31	2004-07-22	Merck Patent Gmbh	Type 4 phosphodiesterase inhibitors and uses thereof.
UA82323C2 (en) *	2002-08-09	2008-04-10	Меда Фарма Гмбх & Ко. Кг	Novel combination of a glucocorticoid and pde-inhibitor for the treatment of respiratory diseases, allergic diseases, asthma and chronic obstructive pulmonary diseases
TW200410923A (en) *	2002-10-17	2004-07-01	Ono Pharmaceutical Co	Therapeutic agent for chronic obstructive pulmonary disease
WO2004087149A1 (en) *	2003-03-31	2004-10-14	Kyowa Hakko Kogyo Co. Ltd.	Medicinal composition
US20050026883A1 (en) *	2003-07-31	2005-02-03	Robinson Cynthia B.	Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
CA2584169A1 (en) *	2004-10-13	2006-04-20	Kyowa Hakko Kogyo Co., Ltd.	Remedies/preventives for chronic skin disease
WO2007045980A1 (en) *	2005-10-19	2007-04-26	Ranbaxy Laboratories Limited	Compositions of phosphodiesterase type iv inhibitors
US8991390B2 (en)	2010-01-05	2015-03-31	Microdose Therapeutx, Inc.	Inhalation device and method
WO2015063669A1 (en)	2013-10-30	2015-05-07	Wockhardt Limited	Pharmaceutical compositions comprising combination of roflumilast and acebrophylline or pharmaceutically acceptable salts thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU7174794A (en) *	1993-06-18	1995-01-17	Smithkline Beecham Corporation	Compounds
DE4332041C2 (en) *	1993-09-21	1997-12-11	Rentschler Arzneimittel	Use of pentoxifylline in certain lung diseases
PE44995A1 (en) *	1994-01-27	1995-12-18	Schering Corp	MOMETASONE FUROATE FOR THE TREATMENT OF LUNG DISEASES AND RESPIRATORY TRACT
SE9801368D0 (en) *	1998-04-20	1998-04-20	Astra Ab	New use

2000
- 2000-10-31 AR ARP000105742A patent/AR029189A1/en not_active Application Discontinuation
- 2000-10-31 EC EC2000003747A patent/ECSP003747A/en unknown
- 2000-11-01 WO PCT/US2000/030113 patent/WO2001032127A2/en active Search and Examination
- 2000-11-01 EP EP00975533A patent/EP1225866A4/en not_active Withdrawn
- 2000-11-01 JP JP2001534335A patent/JP2003513028A/en active Pending
- 2000-11-01 AU AU13575/01A patent/AU1357501A/en not_active Abandoned
- 2000-11-01 BR BR0015270-6A patent/BR0015270A/en not_active IP Right Cessation
- 2000-11-01 CA CA002388333A patent/CA2388333A1/en not_active Abandoned
- 2000-11-01 CN CN00815265A patent/CN1387404A/en active Pending
- 2000-11-01 IL IL14936700A patent/IL149367A0/en unknown
- 2000-11-01 EA EA200200518A patent/EA200200518A1/en unknown
- 2000-11-01 TR TR2002/01211T patent/TR200201211T2/en unknown
- 2000-11-01 HU HU0203152A patent/HUP0203152A3/en unknown
- 2000-11-01 CZ CZ20021512A patent/CZ20021512A3/en unknown
- 2000-11-01 MX MXPA02004350A patent/MXPA02004350A/en unknown
- 2000-11-01 AP APAP/P/2002/002496A patent/AP2002002496A0/en unknown
- 2000-11-01 SK SK759-2002A patent/SK7592002A3/en unknown
- 2000-11-01 OA OA1200200124A patent/OA12076A/en unknown
- 2000-11-01 PL PL00355261A patent/PL355261A1/en not_active Application Discontinuation
- 2000-11-01 DZ DZ003225A patent/DZ3225A1/en active
- 2000-11-01 KR KR1020027005609A patent/KR20020057988A/en not_active Application Discontinuation
- 2000-11-02 PE PE2000001168A patent/PE20011005A1/en not_active Application Discontinuation
- 2000-11-02 CO CO00083427A patent/CO5261512A1/en not_active Application Discontinuation
- 2000-11-22 TW TW089123039A patent/TWI242431B/en not_active IP Right Cessation
2002
- 2002-04-30 NO NO20022057A patent/NO20022057L/en not_active Application Discontinuation
- 2002-04-30 ZA ZA200203435A patent/ZA200203435B/en unknown
- 2002-05-02 MA MA26621A patent/MA26841A1/en unknown
- 2002-05-29 BG BG106748A patent/BG106748A/en unknown
- 2002-12-19 HK HK02109234.5A patent/HK1049107A1/en unknown

Also Published As

Publication number	Publication date
EP1225866A4 (en)	2004-04-21
CN1387404A (en)	2002-12-25
AR029189A1 (en)	2003-06-18
WO2001032127A3 (en)	2001-12-06
TWI242431B (en)	2005-11-01
PL355261A1 (en)	2004-04-05
OA12076A (en)	2006-05-04
JP2003513028A (en)	2003-04-08
IL149367A0 (en)	2002-11-10
HK1049107A1 (en)	2003-05-02
PE20011005A1 (en)	2001-09-28
NO20022057D0 (en)	2002-04-30
ECSP003747A (en)	2002-05-23
CO5261512A1 (en)	2003-03-31
AU1357501A (en)	2001-05-14
CZ20021512A3 (en)	2003-04-16
SK7592002A3 (en)	2002-11-06
CA2388333A1 (en)	2001-05-10
KR20020057988A (en)	2002-07-12
WO2001032127A2 (en)	2001-05-10
NO20022057L (en)	2002-06-27
EA200200518A1 (en)	2002-10-31
MXPA02004350A (en)	2002-11-07
HUP0203152A3 (en)	2004-06-28
BG106748A (en)	2003-02-28
MA26841A1 (en)	2004-12-20
HUP0203152A2 (en)	2003-01-28
TR200201211T2 (en)	2002-08-21
BR0015270A (en)	2002-06-18
EP1225866A2 (en)	2002-07-31
ZA200203435B (en)	2003-06-25
AP2002002496A0 (en)	2002-06-30

Publication	Publication Date	Title
DE69509544D1 (en)	1999-06-10	COMPOSITION FOR THE TREATMENT OF OVARIAL OSTROGEN-DEPENDENT DISEASES
DE60023128D1 (en)	2006-02-23	PYRAZOLECARBOXAMIDE FOR THE TREATMENT OF FATIBILITY AND OTHER DISEASES
DE60124302D1 (en)	2006-12-14	THIAZONE DERIVATIVES FOR THE TREATMENT OF PPAR-LIFE DISEASES
FR13C0060I2 (en)	2014-04-11	FLUORO-SUBSTITUTED OMEGA-CARBOXYARYLDIPHENYLUREA FOR THE TREATMENT AND PREVENTION OF DISEASES AND CONDITIONS
MA26992A1 (en)	2004-12-20	PHENETHANOLAMINE DERIVATIVES FOR THE TREATMENT OF RESPIRATORY DISEASES
EP1416961A4 (en)	2005-12-14	Composition and method for the treatment of disease
DE60022916D1 (en)	2006-02-09	Reboxetine for the treatment of peripheral neuropathies
FIU20060389U0 (en)	2006-09-22	Treatment of bone diseases
MA27027A1 (en)	2004-12-20	PDE4 INHIBITOR AND ASSOCIATED ANTICHOLINERGIC AGENT FOR THE TREATMENT OF OBSTRUCTIVE AIRWAY DISEASES
DE60224163D1 (en)	2008-01-31	COMBINATIONS OF EZETIMIBE AND ASPIRIN FOR THE TREATMENT OF CARDIOVASCULAR DISEASES
DE60123238D1 (en)	2006-11-02	COMPOSITIONS FOR THE TREATMENT OF AUTOIMMUNE DISEASES
DE60027290D1 (en)	2006-05-24	SCLER APROTHESIS FOR THE TREATMENT OF WEIGHTNESS AND OTHER EYE DISEASES
EP1560593A4 (en)	2008-08-20	Novel composition and methods for the treatment of immune related diseases
ATE451123T1 (en)	2009-12-15	VAGINAL ADMINISTERED COMPOSITION FOR THE TREATMENT OF UTERINE DYSRHYTHMIA
DE60204466D1 (en)	2005-07-07	INTEGRINMA TREATMENT FOR THE TREATMENT OF EYE DISEASES
ATE201992T1 (en)	2001-06-15	CARBOSTYRIL DERIVATIVE FOR THE TREATMENT OF OPHTHALMOLOGICAL DISEASES
HUP0302718A3 (en)	2011-03-28	Methods and compositions for the treatment of diseases of the eye
HUP0401392A3 (en)	2012-09-28	Use of composition comprising anti-hla-antibody for treatment of diseases involving prolierative immune response
DZ3225A1 (en)	2001-05-10	METHOD AND COMPOSITIONS FOR THE TREATMENT OF LUNG DISEASES
DE50013843D1 (en)	2007-01-18	MEDICAMENT FOR THE TREATMENT OF DARMER DISEASES
IL155174A0 (en)	2003-10-31	Methods and compositions for the treatment of inflammatory diseases
EP1425027A4 (en)	2008-02-13	Method and composition for treatment of wounds and burns
DE60016047D1 (en)	2004-12-23	DIHYDROBENZOPYRANE, DIHYDROBENZOTHIOPYRANE AND TETRAHYDROCHINOLINE FOR THE TREATMENT OF COX-2-DEPENDENT DISEASES
EE200400074A (en)	2004-06-15	Compositions and their use in the treatment of proliferative diseases
DE69913380D1 (en)	2004-01-15	COMPOSITION FOR THE TREATMENT OF PERIODONTAL DISEASES